Search Press releases Keywords From To 3 Jan 2022 Disposals of own shares Read More 21 Dec 2021 Disposals of own shares Read More 16 Dec 2021 Positive Top-Line Results for BIMZELX[®]▼(bimekizumab) in Phase 3 Ankylosing Spondylitis Trial Read More 10 Dec 2021 UCB announces positive Phase 3 results for rozanolixizumab in generalized myasthenia gravis Read More 3 Dec 2021 Disposals of own shares Read More 3 Dec 2021 UCB to present new data at the American Epilepsy Society 75th Annual Meeting 2021 reinforcing long-standing commitment to advancing epilepsy treatment and care Read More Pagination First page Previous page Previous … Page 37 Page 38 Page 39 Page 40 Current page 41 Page 42 Page 43 Page 44 Page 45 … Page 41 of 66 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
